# The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study

> **NCT04818034** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 10 (actual)

## Conditions studied

- Cystinuria

## Interventions

- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT04818034
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-30
- **Primary completion:** 2021-12-13
- **Final completion:** 2022-04-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818034, "The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04818034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*